title: NSAID-sensitive patients tolerate rofecoxib.
authors.affiliation: Servei de Pneumologia i Allergia Respiratoria, Hospital Clinic, Villarroel, 17008036, Barcelona, Spain. cpicado@medicina.ub.es
authors.forename: A
authors.initials: A
authors.lastname: Valero
authors.forename: M
authors.initials: M
authors.lastname: Baltasar
authors.forename: E
authors.initials: E
authors.lastname: Enrique
authors.forename: L
authors.initials: L
authors.lastname: Pau
authors.forename: M T
authors.initials: MT
authors.lastname: Dordal
authors.forename: A
authors.initials: A
authors.lastname: Cisteró
authors.forename: E
authors.initials: E
authors.lastname: Martí
authors.forename: C
authors.initials: C
authors.lastname: Picado
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000799:Angioedema / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D001249:Asthma / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology; D018849:Controlled Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000503:physiopathology; D004361:Drug Tolerance; D005260:Female; D005541:Forced Expiratory Volume / Q000502:physiology; D006801:Humans; D007783:Lactones / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010366:Peak Expiratory Flow Rate / Q000502:physiology; D016037:Single-Blind Method; D013450:Sulfones; D014581:Urticaria / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib